StemCells, Inc. Reports Second Quarter 2014 Financial Results and Provides Business Update
August 12, 2014 16:02 ET
|
StemCells, Inc.
NEWARK, Calif., Aug. 12, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Announces Webcast to Discuss Second Quarter 2014 Financial Results
August 05, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., Aug. 5, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Announces Closing of $20 Million Offering
July 18, 2014 13:39 ET
|
StemCells, Inc.
NEWARK, Calif., July 18, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), today announced that it has closed its previously announced offering of common stock and short term warrants. The...
StemCells, Inc. Announces Proposed $20 Million Offering
July 15, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., July 15, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), today announced its intent to offer and sell 11,299,435 shares of common stock and short term warrants for the purchase...
StemCells, Inc. Appoints Dr. Alan Trounson to Board of Directors
July 07, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., July 7, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today the appointment of Alan Trounson, Ph.D. to its Board of Directors. Dr. Trounson most recently served as...
StemCells, Inc. President and CEO Martin McGlynn to Present on a Regenerative Medicine Panel at the 2014 BIO International Convention
June 23, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., June 23, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that President and CEO Martin McGlynn will be a panelist at the 2014 BIO International Convention on...
StemCells, Inc. Announces Closure of Enrollment in Phase I/II Dry Age-Related Macular Degeneration Trial
June 20, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., June 20, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) yesterday announced that based on positive interim results, it has closed enrollment in its Phase I/II clinical trial...
StemCells, Inc. Interim Results Show Improvement in Visual Function and Slowing of Disease Progression in Phase I/II Dry AMD Trial
June 19, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., June 19, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) reported positive interim results from its Phase I/II clinical trial of the Company's proprietary HuCNS-SC® human...
StemCells, Inc. Strengthens Senior Executive Team
June 17, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., June 17, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today one promotion and three new appointments to the Company's executive team. Stephen Huhn, M.D., F.A.C.S.,...
StemCells, Inc. to Participate at the 4th LD Micro Invitational Conference
May 29, 2014 17:23 ET
|
StemCells, Inc.
NEWARK, Calif., May 29, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that management will present at the 4th LD Micro Invitational Conference, on Wednesday, June 4, at 11:30...